Ocuphire Pharma
Stock Forecast, Prediction & Price Target
Ocuphire Pharma Financial Estimates
Ocuphire Pharma Revenue Estimates
Ocuphire Pharma EBITDA Estimates
Ocuphire Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $589K N/A | $39.85M 6665.70% | $19.04M -52.19% | Avg: $65.05M Low: $33.17M High: $118.09M avg. 241.49% | Avg: $109.69M Low: $55.93M High: $199.13M avg. 68.62% | Avg: $214.11M Low: $109.18M High: $388.69M avg. 95.18% | Avg: $289.29M Low: $147.51M High: $525.17M avg. 35.11% |
Net Income
% change YoY
| $-56.53M N/A | $17.88M 131.64% | $-9.98M -155.82% | Avg: $43.03M Low: $-11.22M High: $86.35M avg. 530.91% | Avg: $72.14M Low: $4.96M High: $119.39M avg. 67.66% | Avg: $100.82M Low: $36.58M High: $207.69M avg. 39.74% | Avg: $145.13M Low: $52.66M High: $298.97M avg. 43.94% |
EBITDA
% change YoY
| $-22.86M N/A | $18.21M 179.66% | $-9.96M -154.73% | Avg: $11.74M Low: $5.98M High: $21.32M avg. 217.83% | Avg: $19.80M Low: $10.10M High: $35.95M avg. 68.62% | Avg: $38.66M Low: $19.71M High: $70.18M avg. 95.18% | Avg: $52.23M Low: $26.63M High: $94.82M avg. 35.11% |
EPS
% change YoY
| -$3.81 N/A | $0.9 123.62% | -$0.46 -151.11% | Avg: $1.74 Low: -$0.52 High: $4 avg. 478.26% | Avg: $2.88 Low: $0.23 High: $5.53 avg. 65.51% | Avg: $4.67 Low: $1.69 High: $9.62 avg. 62.15% | Avg: $6.72 Low: $2.44 High: $13.85 avg. 43.94% |
Operating Expenses
% change YoY
| $23.29M N/A | $21.62M -7.16% | $29.60M 36.91% | Avg: $215.93M Low: $110.11M High: $392.01M avg. 629.37% | Avg: $364.13M Low: $185.68M High: $661.04M avg. 68.62% | Avg: $710.74M Low: $362.43M High: $1.29B avg. 95.18% | Avg: $960.31M Low: $489.69M High: $1.74B avg. 35.11% |
FAQ
What is Ocuphire Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 170.56% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -11.22M, average is 43.03M and high is 86.35M.
What is Ocuphire Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 110.10% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $33.17M, average is $65.05M and high is $118.09M.
What is Ocuphire Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 162.46% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.52, average is $1.74 and high is $4.